VitaLonga Daily Brief — November 8, 2026

Sunday, November 8, 2026 · 21 minutes

Valeria and Vitalis on caffeinated coffee and dementia rates, vitamin D supplements in football players, vanadyl sulfate and survival in male mice, senescence blood markers before heart surgery, sleep apnea questionnaires after age sixty five, acarbose taken with a rice meal, a skin temperature gap during dialysis, lumbar spine density and long bone fractures, amyloid plaques in women with Parkinson's, and lifting speed and everyday function after sixty. Educational only.

Stories from this day

In 1,880 older adults already taking a statin, a trial found stopping was noninferior to continuing at 2 years, with more events in the stop group · NEJM
In 5,179 people with moderate or severe ischemia, an invasive strategy did not lower 11-year mortality · JAMA
In 251 hospitalized older adults, a few Torque teno virus species lined up with frailty and cognitive impairment, and not with short-term mortality after adjustment · GeroScience
In 3,048 people with atherosclerotic cardiovascular disease, starting ezetimibe with a statin did not cut events versus a statin alone over 3 years · Circulation
In 14,665 adults, an AI electrocardiogram flagged slightly more atrial findings in 90 days, and one swapped event would erase the result · Circulation
In 6,376 adults with atherosclerotic cardiovascular disease and chronic kidney disease, monthly ziltivekimab did not lower major cardiovascular events · NEJM
After adjustment, depression or anxiety lined up with a small rise in late atrial fibrillation in 44,338 people who had cardiac surgery, mainly in men · European Heart Journal Open
In genetic data from hundreds of thousands of women, a lower Lp(a) signal was not tied to worse pregnancy or fertility outcomes · European Heart Journal Open
In 9,476 adults in Brazil with type 2 diabetes and high cardiovascular risk, a systolic target under 120 mm Hg did not reduce major events versus under 140 · NEJM
In notes on 28,113 people, most of those above their LDL goal had no escalation of lipid-lowering therapy · JAMA Cardiology
A reanalysis found a near-zero gene-level link between hypothalamic stem-cell microRNA targets and hypothalamic aging transcriptomes · GeroScience

VitaLonga is an educational longevity resource, not a pharmacy, clinic, or doctor. Content is not medical advice and is not intended to diagnose, treat, cure, or prevent any disease (DSHEA). Supplements can interact with medications and are not appropriate in every pregnancy or health condition. Consult a licensed clinician, especially if you take medications, are pregnant or nursing, or have a diagnosed condition.